Abstract Submissions

Abstract Submissions are now open!

All ASRS member physicians are invited to submit abstracts for the 44^th Annual Meeting, a forum for retina specialists from around the world to share the most recent scientific concepts, techniques, and research. General abstract submissions are open until 11:59 PM Central Time on January 28, 2026.

Abstract submission types will include paper/paper on demand, poster, case, and film. The meeting program will emphasize practical treatment modalities that can be applied to patients immediately.

For abstracts to be considered for a podium presentation, the following characteristics are preferred:

Investigator-led studies on innovative ideas that focus on surgical-oriented techniques, instrumentation, and outcomes.
Novel and clinically relevant research not previously presented at a major eye meeting.
Well-designed studies. Note that acceptance decisions by the Program Committee will not necessarily be based on study size alone as we look to incorporate a broader spectrum of practical cases, both surgical and medical, that will help the clinician improve patient care.
Sound statistical analysis, when indicated.
Conclusion accurately reflects results and takes into account study limitations.

All abstracts are considered equally for selection; the quality of the abstract is the single most important factor in the Program Committee's decision. Please review our Abstract Submission Guide for general and technical instructions.

View requirements by abstract type

NOTE: Lead authors must attest to maintain complete control of educational content beginning with abstract submission through upload of the presentation. Presentations that contain industry data must reflect the lead author’s interpretation of the results.

It is never appropriate for ineligible companies (or advertising, marketing, or communication firms whose clients are ineligible companies) to contact ASRS staff directly.

Abstract limits for lead authors are as follows:

Regular, International, Internationally Trained Ophthalmologists, and Fellow in Training Members: Choose ONE of the following abstract types: Paper/Paper on Demand, First Time Phase 2/Phase 3 Data Presentation, OR poster only. One case: surgical or medical. Two films maximum.
Ophthalmology Resident Members: One poster abstract.
Physician Non-members and Medical Students: One poster abstract. Non-members should log onto their ASRS profile (first time users click "Create an Account") to submit a poster abstract. At least one ASRS member must be listed as co-author.
Co-authors: There is no limit to the number of abstracts on which an ASRS member may be named as co-author.

NOTE: employees and owners of ineligible companies may not submit abstracts, including posters. Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Members and non-members: please log on to your ASRS account to submit an abstract. If you do not currently have an ASRS account, please click “create an account” when prompted. Once your account is set up, return to this page in order to complete your abstract submission.

SUBMIT AN ABSTRACT

IMPORTANT: please be sure to read the FAQs about financial disclosures, especially if you hold an executive role with an ineligible company (i.e., named title such as Chief Officer).

CLICK HERE FOR FAQS ABOUT FINANCIAL DISCLOSURES

Deadline to become a member to submit an abstract

IMPORTANT: January 5, 2026 is the last day to apply for membership to be eligible to submit an abstract for the Annual Meeting. All required documents and references must be received by this date in order for your application to be considered complete.

ASRS members must be current on annual dues payment in order to submit an abstract.

Late-breaking abstracts

ASRS Regular, FIT, and International Members are invited to submit one late-breaking abstract even if they have already accepted an invitation to present a paper at the 2026 Annual Meeting. However, the original paper will be presented as a paper-on-demand since members are limited to one podium talk.

🧠 Content: These abstracts present new, significant, and time-sensitive findings—often from major clinical trials, groundbreaking studies, or pivotal translational research.
🕒 Timing: They are submitted later than standard abstracts (usually a few months before the meeting) but are accepted for review because of their immediacy and relevance.
🎯 Purpose: The goal is to ensure that the conference includes the most current and impactful scientific data, even if those results weren’t ready at the time of regular submissions.
🌍 Examples: You often see LBAs at meetings like ARVO, AAO, ASRS, or ASCO, where new clinical trial results (e.g., a novel gene therapy or anti-VEGF study) are first unveiled.

In short, a Late-Breaking Abstract is a last-minute but high-value addition—something exciting and newly discovered that can influence clinical practice or future research. Late-breaking submissions will be accepted April 22 through June 3.

Notifications

The final Scientific Program will be determined in April 2026 and all presenting/first authors will be contacted at the email address supplied at the time of submission. It is the sole responsibility of the presenting/first author to contact the ASRS before the acceptance deadline on April 22, 2026 if you have not received email notification.

Educational Objectives and Purpose

The goal of the ASRS 44^th Annual Meeting is to improve the competence of vitreoretinal specialists to diagnose and treat vitreous and retinal disorders and diseases using the most advanced concepts and techniques available. The ASRS 44^th Annual Meeting will provide a forum for rapid dissemination of the most recent scientific research results to the target audience in attendance. Its purpose is to allow the presentation of new and ongoing research data to assist practicing vitreoretinal specialists in maintaining knowledge and skills in their medical field.

Upon completion of the scientific sessions, participants shall be able to describe the findings, diagnosis, and treatment of various vitreoretinal disorders such as macular degeneration, choroidal neovascularization, diabetic retinopathy, venous occlusive disease, macular holes, epiretinal membranes, ocular inflammatory disease, tumors, proliferative vitreoretinopathy, retinopathy of prematurity, retinal degenerations, and retinal detachment.

CME Credit Statement

The American Society of Retina Specialists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Notifications and Deadlines

January 5, 2026

Last day to apply for membership (all references and documentation must be received on or before this date)

January 28, 2026

Abstract deadline for papers/papers on demand, posters, cases, and films

April 8, 2026

Notifications sent out for papers/papers on demand, posters, and films

April 15, 2026

Notifications sent out for cases

April 22, 2026

Deadline to accept invitations to present papers, papers on demand, posters, cases, and films

April 22, 2026

Late breaking & WinR abstract submissions open

May 8, 2026

Speaker guidelines and presentation upload instructions sent to lead authors

May 11, 2026

Last date to become a member to register for the Annual Meeting

May 20, 2026

Completed Film Festival video uploads

June 3, 2026

Completed papers-on-demand and cases-on-demand

June 3, 2026

Late breaking abstract submissions close at 11:59 PM CT

June 10, 2026

Completed E-poster uploads

June 10, 2026

Notifications for late breaking abstracts and WinR cases

June 23, 2026

Final Retina Case Conference slide decks

July 8, 2026

Podium slide decks

Questions?

Stacy Kiff
Vice President of Education
(312) 477-8863
stacy.kiff@asrs.org